DVL Stock Overview
Engages in the development and sale of motion analysis technologies in Australia, Europe, and the United States.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
dorsaVi Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.011 |
| 52 Week High | AU$0.032 |
| 52 Week Low | AU$0.01 |
| Beta | 1.24 |
| 11 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | 0% |
| 33 Year Change | -42.11% |
| 5 Year Change | -73.17% |
| Change since IPO | -97.56% |
Recent News & Updates
Recent updates
Shareholder Returns
| DVL | AU Medical Equipment | AU Market | |
|---|---|---|---|
| 7D | 0% | 0.3% | 0.3% |
| 1Y | 0% | 12.3% | 16.0% |
Return vs Industry: DVL underperformed the Australian Medical Equipment industry which returned 12.3% over the past year.
Return vs Market: DVL underperformed the Australian Market which returned 16% over the past year.
Price Volatility
| DVL volatility | |
|---|---|
| DVL Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 9.5% |
| Market Average Movement | 8.9% |
| 10% most volatile stocks in AU Market | 17.2% |
| 10% least volatile stocks in AU Market | 3.6% |
Stable Share Price: DVL's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine DVL's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2008 | n/a | Andrew Ronchi | www.dorsavi.com |
dorsaVi Ltd engages in the development and sale of motion analysis technologies in Australia, Europe, and the United States. It operates through two segments: Clinical and Workplace. The company provides ViMove+, a clinical and sports solutions; ViSafe, a wearable sensor technology that analyzes how workforce moves and reviews and pinpoints unsafe work practices that leads to workplace injury; and myViSafe technology for organizations and on-site clinicians to identify and mitigate injury risk in the workplace and drive behavioral changes.
dorsaVi Ltd Fundamentals Summary
| DVL fundamental statistics | |
|---|---|
| Market cap | AU$6.70m |
| Earnings (TTM) | -AU$1.25m |
| Revenue (TTM) | AU$1.30m |
5.1x
P/S Ratio-5.4x
P/E RatioIs DVL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| DVL income statement (TTM) | |
|---|---|
| Revenue | AU$1.30m |
| Cost of Revenue | AU$123.49k |
| Gross Profit | AU$1.18m |
| Other Expenses | AU$2.43m |
| Earnings | -AU$1.25m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0019 |
| Gross Margin | 90.52% |
| Net Profit Margin | -95.80% |
| Debt/Equity Ratio | 4.9% |
How did DVL perform over the long term?
See historical performance and comparison